Ikena Oncology, Inc. announced on July 11, 2025, that proxy advisory firms recommend stockholders vote "FOR" the share issuance related to their merger with Inmagene, planned for the Annual Meeting on July 15, 2025. The merger involves two subsidiary mergers culminating in Inmagene becoming a part of Ikena, which was initially announced on December 23, 2024.